Helen Sabzevari, President and CEO at PRECIGEN, INC. (PGEN), sold 5,450 shares at $3.01 ($16K) on 2020-04-01, disclosed to the SEC on 2020-04-02.
Scheduled sale ($16k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PGEN | SELL | 2023-08-25 | $236K | — | Filing → |
| PGEN | SELL | 2023-08-18 | $185K | — | Filing → |
| PGEN | SELL | 2023-08-11 | $119K | — | Filing → |